Zigakibart not checked
Novartis · BION-1301 · FUB523
FollowEvery change as it happens, and a Monday email
Trials
5 active
6 in total · 4 in the EU
Targets
—
None known yet
What this is
- How it works
- An antibody: a lab-made immune protein built to latch onto one target in the body.-bart: artificial immunoglobulins WHO name stem
- How it’s given
- “BION-1301 Pre-Filled Syringe (PFS) 600mg subcutaneous administration every 2 weeks for 104 weeks.”In the company’s words, NCT05852938 on ClinicalTrials.gov
- Tested for
- IgA Nephropathy (2 trials), Immunoglobulin A Nephropathy (2 trials), IgA Nephropathy (IgAN), Kidney Diseases, Kidney Diseases, Chronic, Urological Diseases, Glomerulonephritis, Glomerular Disease and 4 more
- Main trialPhase 3
- “Safety and Efficacy of BION-1301 in Adults with IgA Nephropathy”In the company’s words, NCT05852938 on ClinicalTrials.gov
- Other names
- BION-1301 · FUB523
Other drugs for IgA Nephropathy
Coming up5
- 10 Aug 2027Phase 3 trial completes · ClinicalTrials.gov
- 14 Apr 2028Phase 3 trial completes · ClinicalTrials.gov
- 17 Sep 2028Phase 3 trial completes · ClinicalTrials.gov
- 12 Jul 2030Phase 2 trial completes · ClinicalTrials.gov
- 25 Jun 2031Phase 3 trial completes · ClinicalTrials.gov
Changes0
Last 90 daysNo changes yet. We started recording changes on 6 Nov 2026.
Trials6
| Trial | Phase | Completes | What it tests |
|---|---|---|---|
| Phase 3Active, not recruiting | 10 Aug 2027 | A Study of Zigakibart in Adults With IgA Nephropathy | |
| Phase 3Active, not recruiting | 14 Apr 2028 | Atrasentan in Patients With IgA Nephropathy | |
| Phase 3Not yet recruiting | 17 Sep 2028 | A Study of the Efficacy and Safety of Zigakibart + Atrasentan in Adult Patients With Primary IgA Nephropathy | |
| Phase 3Recruiting | 25 Jun 2031 | Open-label Extension Study of Zigakibart in Adults With IgA Nephropathy. | |
| Phase 2Recruiting | 12 Jul 2030 | A Study to Assess the Effects of Zigakibart on IgA Nephropathy. | |
| Phase 1/2Completed | 10 Jun 2026 | Safety and Tolerability of BION-1301 in Healthy Volunteers and Adults With IgA Nephropathy (IgAN) |
A trial in both registries shows both numbers.
About
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 · EU trials register (CTIS) updated 18 Nov 2026 · openFDA updated 17 Nov 2026